Point72 Asset Management, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ)

Filing Manager: Point72 Asset Management, L.P.
Reporting Manager: Steven A. Cohen
Security: LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: LENZ
Shares outstanding: 28.3M shares
Disclosed Ownership: 1.36M shares
Ownership: 4.8%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:03 PM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Point72 Asset Management, L.P.	1.2%	340K	340K	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc.	1.2%	340K	340K	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Biotech Private Investments, LLC	3.6%	1.02M	1.02M	/s/ Vincent Tortorella	Vincent Tortorella, Authorized Person
Differentiated Ventures Investments, LLC	3.6%	1.02M	1.02M	/s/ Vincent Tortorella	Vincent Tortorella, Authorized Person
72 Investment Holdings, LLC	3.6%	1.02M	1.02M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Steven A. Cohen	4.8%	1.36M	1.36M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person